UBS Group
XYN

UBS Group’s Xynomic Pharmaceuticals Holdings, Inc. Common Stock XYN Stock Holding History

UBS Group’s Portfolio XYN Stock Details XYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,357
Closed -$5K – 7432
2019
Q2 		$5K Buy
+1,357
New +$5K ﹤0.01% 6547